JPRN-UMIN000008781招募中2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung cancer - Phase II Study of PEM+BEV for previously untreated elderly patients with nonsquamous non-small-cell lung cancer
Toho university medical center sakura hospital0 个研究点目标入组 25 人开始时间: 2012年8月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of active double cancer within 5 years. 2) Severe infection 3) History of hemoptysis with 2.5mL or more. 4) Continued bloody phlegm. 5) Received anticoagulant drug(including Aspirin over 325mg/day) within the past 10 days. 6) Perforation of the digestive tract or history of the perforation of the digestive tract within the past one year. 7) Severe comorbidity (heart failure Tendency to hemorrhages uncontrollable hypertension, uncontrollable diabetes, etc) 8) Arterial thromboembolism and Venous thromboembolism within the past one year. 9)Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 10) Planning of surgery or thoracic radiotherapy during the trial. 11) Major surgical procedure 12)With a history of drug sensitivity. 13)Pregnant or lactating women or those who declined contraception. 14) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
研究者
相似试验
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutatioon-small cell lung cancerJPRN-UMIN000008032Toho University Omori Medical Center15
已完成
2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)non-small cell lung cancerJPRN-UMIN000009539OSAKA-LCSG45
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36
招募中
2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.JPRN-UMIN000008124iigata Lung Cancer Treatment Group25